(Total Views: 535)
Posted On: 08/01/2020 8:17:33 AM
Post# of 145257
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
IMHO the study will show some Milds who never progressed to moderate,,, will show very little further disease progression symptoms whether in placebo or treatment arm ( that might hurt p value ) .. And that treatment group will never be approved for further treatment anyway. That’s why the different designation explanation in my view .
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)